Published on: September 23, 2020 at 09:30PM
Conditions: Diabetes Mellitus, Type 2; Peripheral Arterial Disease
Interventions: Drug: Semaglutide; Drug: Placebo (semaglutide)
Sponsor: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3kBBF12
Wednesday, 23 September 2020
New diabetes clinical trial: A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.